about
Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions.Prostate cancer in the era of "Omic" medicine: recognizing the importance of DNA damage repair pathways.Microsatellite instability in prostate cancer by PCR or next-generation sequencing.Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defectsDendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MSH2 Loss in Primary Prostate Cancer.
@en
MSH2 Loss in Primary Prostate Cancer.
@nl
type
label
MSH2 Loss in Primary Prostate Cancer.
@en
MSH2 Loss in Primary Prostate Cancer.
@nl
prefLabel
MSH2 Loss in Primary Prostate Cancer.
@en
MSH2 Loss in Primary Prostate Cancer.
@nl
P2093
P2860
P1476
MSH2 Loss in Primary Prostate Cancer.
@en
P2093
Angelo M De Marzo
Colin C Pritchard
Emmanuel S Antonarakis
Fawaz Almutairi
James R Eshleman
Jessica Hicks
Jonathan I Epstein
Jong Chul Park
Liana B Guedes
Mario A Eisenberger
P2860
P304
P356
10.1158/1078-0432.CCR-17-0955
P407
P577
2017-08-08T00:00:00Z